Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement
Author:
Publisher
Elsevier BV
Subject
Immunology and Allergy
Reference8 articles.
1. Hereditary angioedema with normal C1 inhibitor: an evolving diagnosis;Bernstein;Allergy Asthma Proc,2012
2. Successful treatment of idiopathic angioedema with ecallantide;Berry;J Allergy Clin Immunol Pract,2013
3. Resolution of an acute attack of idiopathic angioedema with ecallantide;Dy;Ann Allergy Asthma Immunol,2013
4. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant;Del Corso;Ann Allergy Asthma Immunol,2012
5. Nonhistaminergic idiopathic angioedema: clinical response to icatibant;Colás;J Investig Allergol Clin Immunol,2012
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Life-threatening idiopathic nonhistaminergic acquired angioedema with response to lanadelumab;Journal of Investigational Allergology and Clinical Immunology;2023-07-03
2. Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema;Allergy;2022-07-22
3. The Panorama of Primary Angioedema in the Brazilian Population;The Journal of Allergy and Clinical Immunology: In Practice;2021-06
4. Hereditary Angioedema: Insights into inflammation and allergy;Molecular Immunology;2019-08
5. Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation;Blood;2019-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3